Elanco expands vaccine presence with Titanium and Master Guard purchase
Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced the company will purchase the Titanium® and Master Guard® brands from AgriLabs®. These well-known cattle vaccine brands will complement Elanco’s growing vaccine portfolio, including the recently approved ViralignTM 6, the only modified-live combination vaccine to protect against bovine viral diarrhea (BVD) virus 1b, which is now the most predominant BVD virus strain in the United States.
Elanco will continue to deliver these highly respected brands in the same manner producers have come to expect and will work closely with AgriLabs to ensure a seamless transition. Elanco will support all 2013 programs and pricing, and customers should continue to place orders through existing channels.
“At Elanco, we are committed to providing innovative solutions to enhance food production and companion animal care. We are pleased our growing vaccine portfolio and pipeline will offer Elanco customers a broader array of options to better meet their specific needs for disease prevention,” said Jeff Simmons, president, Elanco. “This is another example of our effort to provide Elanco customers with greater value.”
In the next few decades, global population is expected to exceed 9 billion, and 3 billion will move into the middle class, the fastest middle class growth in our history. With the growing affluence, will come a 60 percent increase in demand for meat, milk and eggs, according to the U.N. Food and Agriculture Organization.
“With beef stocks at all-time lows and demand outpacing dairy supply globally, we must continue to provide innovative solutions that will help producers increase the affordability and availability of animal protein,” said Rob Aukerman, president U.S. operations at Elanco. “We have diversified our portfolio and sources of innovation to deliver more options and solutions to our customers.”